BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32245436)

  • 1. Comparison of serum protein profiles between major depressive disorder and bipolar disorder.
    Rhee SJ; Han D; Lee Y; Kim H; Lee J; Lee K; Shin H; Kim H; Lee TY; Kim M; Kim SH; Ahn YM; Kwon JS; Ha K
    BMC Psychiatry; 2020 Apr; 20(1):145. PubMed ID: 32245436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
    Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
    Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum microbiome composition in bipolar and major depressive disorders.
    Rhee SJ; Kim H; Lee Y; Lee HJ; Park CHK; Yang J; Kim YK; Kym S; Ahn YM
    J Psychiatr Res; 2020 Apr; 123():31-38. PubMed ID: 32028208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.
    Kageyama Y; Kasahara T; Nakamura T; Hattori K; Deguchi Y; Tani M; Kuroda K; Yoshida S; Goto YI; Inoue K; Kato T
    Int J Neuropsychopharmacol; 2018 Mar; 21(3):207-215. PubMed ID: 29040586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced serum levels of neuron specific enolase (NSE) in drug-naïve subjects with major depression and bipolar disorder.
    Wiener CD; Jansen K; Ghisleni G; Kaster MP; Souza LD; Lara DR; Portela LV; da Silva RA; Oses JP
    Neurochem Res; 2013 Jul; 38(7):1394-8. PubMed ID: 23564292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
    Hashimoto K
    Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.
    Giusti L; Mantua V; Da Valle Y; Ciregia F; Ventroni T; Orsolini G; Donadio E; Giannaccini G; Mauri M; Cassano GB; Lucacchini A
    Mol Biosyst; 2014 Jun; 10(6):1246-54. PubMed ID: 24554194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study.
    Bartoli F; Crocamo C; Dakanalis A; Brosio E; Miotto A; Capuzzi E; Clerici M; Carrà G
    Compr Psychiatry; 2017 Feb; 73():1-6. PubMed ID: 27837679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc and copper concentration do not differentiate bipolar disorder from major depressive disorder.
    Styczeń K; Sowa-Kućma M; Dudek D; Siwek M; Reczyński W; Szewczyk B; Misztak P; Topór-Mądry R; Opoka W; Nowak G
    Psychiatr Pol; 2018 Jun; 52(3):449-457. PubMed ID: 30218561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety.
    Schaffer A; Cairney J; Veldhuizen S; Cheung A; Levitt A
    J Clin Psychiatry; 2007 Nov; 68(11):1785-92. PubMed ID: 18052573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic versus non-psychotic bipolar disorder: Socio-demographic and clinical profiles in an Italian nationwide study.
    Altamura AC; Buoli M; Cesana BM; Fagiolini A; de Bartolomeis A; Maina G; Bellomo A; Dell'Osso B;
    Aust N Z J Psychiatry; 2019 Aug; 53(8):772-781. PubMed ID: 30658550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of bipolar disorders in patients with a major depressive episode: the Japanese epidemiological trial with latest measure of bipolar disorder (JET-LMBP).
    Inoue T; Inagaki Y; Kimura T; Shirakawa O
    J Affect Disord; 2015 Mar; 174():535-41. PubMed ID: 25556671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Pu J; Liu Y; Gui S; Tian L; Xu S; Song X; Zhong X; Chen Y; Chen X; Yu Y; Liu L; Zhang H; Wang H; Zhou C; Zhao L; Xie P
    Psychiatry Res; 2020 Oct; 292():113319. PubMed ID: 32717712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.